Epigallocatechin-3-Gallate (EGCG) Suppresses Pancreatic Cancer Cell Growth, Invasion, and Migration partly through the Inhibition of Akt Pathway and Epithelial–Mesenchymal Transition: Enhanced Efficacy When Combined with Gemcitabine

Most pancreatic cancers are usually diagnosed at an advanced stage when they have already metastasized. Epigallocatechin-3-gallate (EGCG), a major polyphenolic constituent of green tea, has been shown to reduce pancreatic cancer growth, but its effect on metastasis remains elusive. This study evalua...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Ran, Cortez Penso, Natalia E., Hackman, Robert M., Wang, Yuefei, Mackenzie, Gerardo G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722696/
https://www.ncbi.nlm.nih.gov/pubmed/31405071
http://dx.doi.org/10.3390/nu11081856

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6722696/
https://www.ncbi.nlm.nih.gov/pubmed/31405071
http://dx.doi.org/10.3390/nu11081856

Ejemplares similares